24 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
1527792	55	Specific inhibition of HIV-1 protease by boronated porphyrins.	University of California
1635057	48	Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors.	Parke-Davis Pharmaceutical Research Division of Warner-Lambert
3045320	37	Design of rat renin inhibitory peptides.	Massachusetts General Hospital
3275777	34	Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.	Upjohn
3543358	96	Pepstatin analogues as novel renin inhibitors.	TBA
3906131	61	Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.	TBA
20731374	65	Direct renin inhibitors as a new therapy for hypertension.	Novartis Pharmaceuticals
19615901	52	The P1N-isopropyl motif bearing hydroxyethylene dipeptide isostere analogues of aliskiren are in vitro potent inhibitors of the human aspartyl protease renin.	Nagasaki International University
	23	Novel low molecular renin inhibitors which show good oral blood pressure lowering effects in marmosets	TBA
	3	CP-71,362, an unusually potent inhibitor of rat and dog renin	TBA
	1	Evaluation of the intestinal permeability and hepatic handling of peptidomimetic analogs	TBA
	12	MDL 74147, a novel selective and soluble inhibitor of human renin. Synthesis, structure-activity relationship, species and protease selectivities.	TBA
15081001	17	The discovery of structurally novel CCR1 antagonists derived from a hydroxyethylene peptide isostere template.	Pfizer
8474102	29	Studies directed toward the design of orally active renin inhibitors. 2. Development of the efficacious, bioavailable renin inhibitor (2S)-2-benzyl-3- [[(1-methylpiperazin-4-yl)sulfonyl]propionyl]-3-thiazol-4-yl-L-alanine amide of (2S,3R,4S)-2-amino-1-cyclohexyl-3,4-dihydroxy-6-methylheptane (A-725	Abbott Laboratories
8410992	35	Renin inhibitors containing a pyridyl amino diol derived C-terminus.	Hoechst
7932521	81	Nonpeptide renin inhibitors with good intraduodenal bioavailability and efficacy in dog.	Abbott Laboratories
3309313	48	Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond.	Abbott Laboratories
3302256	45	Analysis of structure-activity relationships in renin substrate analogue inhibitory peptides.	TBA
3137345	19	Synthesis and biological activity of some transition-state inhibitors of human renin.	Ciba-Geigy
3127587	33	New human renin inhibitors containing an unnatural amino acid, norstatine.	Kissei Pharmaceutical
2202829	18	Inhibitors of human renin. Cyclic peptide analogues containing a D-Phe-Lys-D-Trp sequence.	Ici Pharmaceuticals Group
2197413	8	Potent renin inhibitory peptides containing hydrophilic end groups.	Upjohn
29754833	73	Discovery of benzimidazole derivatives as orally active renin inhibitors: Optimization of 3,5-disubstituted piperidine to improve pharmacokinetic profile.	Takeda Pharmaceutical
1738148	16	Renin inhibitory pentols showing improved enteral bioavailability.	Hoechst